Source:
This report highlights research findings about contraceptive methods published in 2007 and 2008. One section summarizes the new, longer "grace period" for DMPA reinjection recently recommended by the World Health Organization (see pp. 3-5). Another section reviews studies that have addressed issues concerning use of hormonal contraceptives among women with HIV (see pp. 14-16).
- Regions/Countries:
- Global
WHO Upholds Guidance: Women With or at Risk of HIV Can Safely Use Hormonal Methods
WHO released a statement on February 16, 2012, upholding guidance indicating that women with HIV or at high risk of HIV can safely use hormonal contraceptives, including injectables, to prevent pregnancy. However, WHO is instructing health care providers to strongly advise such women who decide to use progestin-only injectables to also always use male or female condoms for protection against HIV. Read more about WHO's statement.
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.